Non-Alcoholic Steatohepatitis Market Share, Size, Growth, Opportunity and Forecast 2023-2028

The latest report by IMARC Group, titled “Non-Alcoholic Steatohepatitis (NASH) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global non-alcoholic steatohepatitis market share. The global market size reached US$ 1.21 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.55 Billion by 2028, exhibiting a growth rate (CAGR) of 27.70% during 2023-2028.

Non-Alcoholic Steatohepatitis Market

Non-alcoholic steatohepatitis (NASH) is a liver condition characterized by inflammation and the accumulation of fat deposits in the liver, absent of excessive alcohol consumption. It is a severe form of non-alcoholic fatty liver disease (NAFLD) and can progress to more critical liver diseases such as cirrhosis and liver cancer if left untreated. NASH is often asymptomatic in its early stages, making it difficult to diagnose without specific tests. It typically affects individuals with obesity, type 2 diabetes, or high cholesterol levels. Due to its chronic nature, the management of NASH generally involves lifestyle changes and may require pharmacological intervention. Given the implications on long-term liver health and the increasing prevalence of NASH, there is a growing necessity for effective treatments and diagnostic methods within the healthcare industry.

Request Your Sample Report Now: https://www.imarcgroup.com/non-alcoholic-steatohepatitis-market/requestsample

Non-Alcoholic Steatohepatitis (NASH) Market Trends and Drivers:

The global non-alcoholic steatohepatitis (NASH) market is primarily driven by the rising incidence of obesity and type 2 diabetes worldwide, both of which are risk factors for developing NASH. As awareness around the condition grows, more healthcare facilities are focusing on early diagnosis and treatment, which in turn fuels the market for NASH-related pharmaceuticals and diagnostic tools. Additionally, ongoing research and development (R&D) in the sector aims to bring more targeted treatments to the market, potentially offering better patient outcomes. In line with this, the increasing adoption of sedentary lifestyles has contributed to the uptick in NASH cases, prompting greater emphasis on preventative healthcare measures, thus propelling market growth. Furthermore, advancements in liver biopsy techniques and imaging studies are providing a positive thrust to the diagnosis sector within the industry, thereby contributing to market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Drug Type Insights:

  • Vitamin E and Pioglitazone
  • Ocaliva
  • Elafibranor
  • Selonsertib
  • Cenicriviroc
  • Others

Disease Cause Insights:

  • Hypertension
  • Heart Disease
  • High Blood Lipid
  • Type 2 Diabetes
  • Obesity

Sales Channel Insights:

  • Hospital Pharmacy
  • Online Providers
  • Retail Pharmacy

End User Insights:

  • Hospitals
  • Clinics
  • Homecare Settings

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Algernon Pharmaceuticals
  • Galmed Pharmaceuticals Ltd
  • Intercept Pharmaceuticals Inc.
  • Zydus Lifesciences Limited

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

 

Comments

Post a Comment

Popular posts from this blog

Vietnam Hospitals Market Growth, Outlook, Scope, Trends and Opportunity 2024-2032

Image
 IMARC Group's report titled " Vietnam Hospitals Market Report by Ownership (Public, Private), Type (General, Multispecialty, Specialty), Type of Service (In-Patient Services, Out-Patient Services), Bed Capacity (Above 500 Beds, 100-500 Beds, Up to 100 Beds), and Region 2024-2032 ". offers a comprehensive analysis of the industry, which comprises insights on the Vietnam hospitals market growth . The market is projected to exhibit a growth rate (CAGR) of 5.85% during 2024-2032. For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/vietnam-hospitals-market/requestsample Factors Affecting the Growth of the Vietnam Hospitals Industry: Growing Population and Aging Demographics: The rising geriatric population combined with the increasing prevalence of chronic diseases represents one of the key factors impelling the market growth in Vietnam. The aging population that is more susceptible to age-related health issues, such as cardiovascular...
Read more

Personal Mobility Devices Market Growth, share, Size, Opportunity and Forecast 2023-2028

Image
 The latest report by IMARC Group, titled “ Personal Mobility Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“ . offers a comprehensive analysis of the industry, which comprises insights on the global personal mobility devices market growth . The global market size reached US$ 12.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028. Personal mobility devices (PMDs) are compact, motorized vehicles designed to assist individuals with mobility impairment in ambulation. These vehicles can be manual or electrically powered, allowing individuals to move freely and independently while providing pain relief and improved mobility. Some commonly available PMDs are walkers, forearm crutches, roll-about, canes, triangular walkers, rolling walkers with seats, and ankle-foot orthotics. They are easy to operate, cost-effective, portable, preven...
Read more

Annatto Market 2023, Size, Growth, Share and Forecast by 2028

Image
The latest report by IMARC Group, titled “ Annatto Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ”. The global annatto market size reached US$ 213.63 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 285.15 Million by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2023-2028. Annatto refers to a natural colorant and flavoring agent obtained from the seeds of the achiote tree. It has a vibrant yellow to orange-red color and is commonly used to add color to food products, including cheese, butter, snacks, etc. Annatto also contains carotenoids, such as bixin and norbixin, that can aid in protecting cells from damage caused by free radicals. In addition to this, it also comprises tocotrienols, a type of vitamin E that assists in minimizing cholesterol levels and improving heart health. As a result, this natural colorant and flavoring agent finds wide-ranging applications in the pharmaceuticals and food and bevera...
Read more